載入...
Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
BACKGROUND: Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. METHODS: CD133+ HPCs were isolated and purified from human...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690192/ https://ncbi.nlm.nih.gov/pubmed/33243165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07633-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|